|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2009-4-15
|
|
pubmed:abstractText |
To investigate the clinical significance of lymphoid neogenesis (LN) in rheumatoid arthritis (RA), the clinicopathological correlates of this process and its evolution after anti-tumour necrosis factor (TNF)alpha therapy in a large series of synovial tissues were analysed.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1468-2060
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
68
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
751-6
|
|
pubmed:meshHeading |
pubmed-meshheading:18495732-Aged,
pubmed-meshheading:18495732-Antigens, CD20,
pubmed-meshheading:18495732-Antigens, CD3,
pubmed-meshheading:18495732-Antirheumatic Agents,
pubmed-meshheading:18495732-Arthritis, Rheumatoid,
pubmed-meshheading:18495732-Arthroscopy,
pubmed-meshheading:18495732-Biopsy,
pubmed-meshheading:18495732-Female,
pubmed-meshheading:18495732-Follow-Up Studies,
pubmed-meshheading:18495732-Humans,
pubmed-meshheading:18495732-Lymphatic Vessels,
pubmed-meshheading:18495732-Lymphocyte Subsets,
pubmed-meshheading:18495732-Male,
pubmed-meshheading:18495732-Middle Aged,
pubmed-meshheading:18495732-Prognosis,
pubmed-meshheading:18495732-Severity of Illness Index,
pubmed-meshheading:18495732-Synovial Membrane,
pubmed-meshheading:18495732-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Clinical significance of synovial lymphoid neogenesis and its reversal after anti-tumour necrosis factor alpha therapy in rheumatoid arthritis.
|
|
pubmed:affiliation |
Unitat d'Artritis, Servei de Reumatología, Hospital Clínic de Barcelona, Barcelona, Spain. jcanete@clinic.ub.es
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
